News Preview
Capricor (CAPR) Q3 2026 Earnings Call Transcript
Capricor (CAPR) expects an FDA decision soon for Deramiocel, preparing for a solo launch.
Want to stay up to date with the world events at sea or at home?
Explore Navvyx News - the best News app for seafarers.